Nrf2:INrf2 (Keap1) signaling in oxidative stress

Free Radical Biology and Medicine

Volumn 47, Issue 9, 2009, Pages 1304-1309

  Kaspar, James W ^a   Niture, Suryakant K ^a   Jaiswal, Anil K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant response element; Free radicals; INrf2; Keap1; Nrf2; Regulation of gene expression

Indexed keywords

ANTIOXIDANT; CADMIUM; CURCUMIN; GLYCOGEN SYNTHASE KINASE 3BETA; HEAVY METAL; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MANGANESE; METHYLMERCURY; OLTIPRAZ; PROTEIN KINASE C; PROTEIN KINASE FYN; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; XENOBIOTIC AGENT;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; CANCER RESISTANCE; CELL PROTECTION; CELL SURVIVAL; CHEMOPROPHYLAXIS; ELECTROPHILIC STRESS; GENE EXPRESSION REGULATION; GENE MUTATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 70349843323     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.035     Document Type: Review

References (101)

1. Breimer L.H. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol. Carcinog. 3 (1990) 188-197
2. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic. Biol. Med. 23 (1997) 783-792
3. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36 (2004) 1199-1207
4. Bauer C.E., Elsen S., and Bird T.H. Mechanisms for redox control of gene expression. Annu. Rev. Microbiol. 53 (1999) 495-523
5. Zheng M., and Storz G. Redox sensing by prokaryotic transcription factors. Biochem. Pharmacol. 59 (2000) 1-6
6. Dhakshinamoorthy S., Long II D.J., and Jaiswal A.K. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr. Top. Cell. Regul. 36 (2000) 201-206
7. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38 (2006) 769-789
8. Kobayashi M., and Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46 (2006) 113-140
9. Copple I.M., Goldring C.E., Kitteringham N.R., and Park B.K. The Nrf2-Keap1 defense pathway: role in protection against drug-induced toxicity. Toxicology 246 (2008) 24-33
10. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. 4th ed. (2007), Oxford Univ. Press, London
11. Rushmore T.H., Morton M.R., and Pickett C.B. The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266 (1991) 11632-11639
12. Rushmore T.H., King R.G., Paulson K.E., and Pickett C.B. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotics-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. USA 87 (1990) 3826-3830
13. Xie T., Belinsky M., Xu Y., and Jaiswal A.K. ARE and TRE-mediated regulation of gene expression: response to xenobiotics and antioxidants. J. Biol. Chem. 270 (1995) 6894-6900
14. Rushmore T.H., and Pickett C.B. Glutathione S-transferases, structures, regulation, and therapeutic implications. J. Biol. Chem. 268 (1993) 11475-11478
15. Jaiswal A.K. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic. Biol. Med. 29 (2000) 252-254
16. Bloom D., Dhakshinamoorthy S., Wang W., Celli C.M., and Jaiswal A.K. Role of NF-E2 related factors in oxidative stress. In: Storey K.B., and Storey J.M. (Eds). Cell and Molecular Responses to Stress, Vol. 2, Protein Adaptation and Signal Transduction. (2001), Elsevier, Amsterdam 229-238
17. Venugopal R., and Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 93 (1996) 14960-14965
18. Alam J., Stewart D., Touchard C., Boinapally S., Choi M.K., and Cook J.L. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274 (1999) 26071-26078
19. Wild A.C., Moinova H.R., and Mulcahy R.T. Regulation of γ-glutamylcysteine synthetase subunit gene expression by transcription factor Nrf2. J. Biol. Chem. 274 (1999) 33627-33636
20. Nguyen T., Huang H.C., and Pickett C.B. Transcriptional regulation of the antioxidant response element: activation by Nrf2 and repression by MafK. J. Biol. Chem. 275 (2000) 15466-15473
21. Andrews N.C., Erdjument-Bromage H., Davidson M.B., Tempst P., and Orikin S.H. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic leucine zipper protein. Nature 339 (1993) 722-727
22. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., Wolf C.R., Cavin C., and Hayes J.D. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61 (2001) 3299-3307
23. Moi P., Chan K., Asunis I., Cao A., and Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. USA 91 (1994) 9926-9930
24. Chan J.Y., Han X.L., and Kan Y.W. Isolation of cDNA encoding human NF-E2 protein. Proc. Natl. Acad. Sci. USA 90 (1993) 11366-11370
25. Mohler J., Mahaffey J.W., Deutsch E., and Vani K. Control of Drosophila head segment identity by the bZIP homeotic gene CNC. Development 121 (1995) 237-247
26. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh K., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997) 313-322
27. Venugopal R., and Jaiswal A.K. Nrf2 and Nrf2 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 17 (1998) 3145-3156
28. Kwak M.K., Cho J.M., Huang B., Shin S., and Kensler T.W. Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic. Biol. Med. 43 (2007) 809-917
29. Hayashi A., Suzuki H., Itoh K., Yamamoto M., and Sugiyama Y. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem. Biophys. Res. Commun. 310 (2003) 824-829
30. Maher J.M., Cheng X., Slitt A.L., Dieter M.Z., and Klaassen C.D. Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab. Dispos. 33 (2005) 956-962
31. Slitt A.L., Cherrington N.J., Dieter M.Z., Aleksunes L.M., Scheffer G.L., Huang W., Moore D.D., and Klaassen C.D. trans-Stilbene oxide induces expression of genes involved in metabolism and transport in mouse liver via CAR and Nrf2 transcription factors. Mol. Pharmacol. 69 (2006) 1554-1563
32. Maher J.M., Dieter M.Z., Aleksunes L.M., Slitt A.L., Guo G., Tanaka Y., Scheffer G.L., Chan J.Y., Manautou J.E., Chen Y., Dalton T.P., Yamamoto M., and Klaassen C.D. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46 (2007) 1597-1610
33. Maher J.M., Aleksunes L.M., Dieter M.Z., Tanaka Y., Peters J., Manautou J.E., and Klaassen C.D. Nrf2 and PPAR{alpha}-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol. Sci. 106 (2008) 319-328
34. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to that amino-terminal Neh2 domain. Genes Dev. 13 (1999) 76-96
35. Dhakshinamoorthy S., and Jaiswal A.K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 20 (2001) 3906-3917
36. Zipper L.M., and Mulcahy R.T. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J. Biol. Chem. 277 (2002) 36544-36552
37. Prag S., and Adams J.C. Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/Kelch proteins in animals. BMC Bioinformatics 4 (2003) 42
38. Albagli O., Dhordain P., Deweindt C., Lecocq G., and Leprince D. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ. 6 (1995) 1193-1198
39. Kim I.F., Mohammadi E., and Huang R.C.C. Isolation and characterization of IPP, a novel human gene coding an actin-binding KELCH-like protein. Gene 228 (1999) 73-83
40. Kang M., Kobayashi A., Wakabayashi N., Kim S., and Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as a key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. USA 101 (2004) 2046-2051
41. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., and Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24 (2004) 7130-7139
42. Cullinan S.B., Gordan J.D., Jin J., Harper J.W., and Diehl J.A. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24 (2004) 8477-8486
43. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., and Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24 (2004) 10941-10953
44. Furukawa M., and Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin3-Rox1 ligase. Mol. Cell. Biol. 25 (2005) 162-171
45. Sekhar K.R., Yan X.X., and Freeman M.L. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene 21 (2002) 6829-6834
46. Stewart D., Killeen E., Naquin R., Alam S., and Alam J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J. Biol. Chem. 278 (2003) 2396-2402
47. Nguyen T., Sherratt P.J., Huang H.C., Yang C.S., and Pickett C.B. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element: degradation of Nrf2 by the 26S proteasome. J. Biol. Chem. 278 (2003) 4536-4541
48. Itoh K., Wakabayashi N., Katoh Y., Ishii T., O'Connor T., and Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8 (2003) 379-391
49. Bloom D.A., and Jaiswal A.K. Phosphorylation of Nrf2 at Ser(40) by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278 (2003) 44675-44682
50. Zhang D.D., and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23 (2003) 8137-8151
51. 1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. Carcinogenesis 8 (1987) 1549-1553
52. Huang H.C., Nguyen T., and Pickett C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277 (2002) 42769-42774
53. Buckley B.J., Marshall Z.M., and Whorton A.R. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem. Biophys. Res. Commun. 307 (2003) 973-979
54. Yu R., Mandlekar S., Weber M.J., Der C.J., Wu J., and Tony-Kong A.N. Role of mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274 (1999) 27545-27552
55. Zipper L.M., and Mulcahy R.T. Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes. Biochem. Biophys. Res. Commun. 278 (2000) 484-492
56. Cullinan S.B., Zhang D., Hannik M., Arvisais E., Kaufman R.J., and Diehl J.A. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23 (2003) 7198-7209
57. Zhang D.D., Lo S.C., Sun Z., Habib G.M., Lieberman M.W., and Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J. Biol. Chem. 280 (2005) 30091-30099
58. Eggler A.L., Liu G., Pezzuto J.M., van Breemen R.B., and Mesecar A.D. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. USA 102 (2005) 10070-10075
59. Jain A.K., Mahajan S., and Jaiswal A.K. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation. J. Biol. Chem. 283 (2008) 17712-17720
60. Niture S.K., and Jaiswal A.K. Prothymosin-a mediates nuclear import of INrf2/Cul3-Rbx1 complex to degrade nuclear Nrf2. J. Biol. Chem. 284 (2009) 13856-13868
61. Lee O., Jain A.K., Papusha V., and Jaiswal A.K. An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J. Biol. Chem. 282 (2007) 36412-36420
62. Igarashi K., Hoshino H., Muto A., Suwabe N., Nishikawa S., Nakauchi H., and Yamamoto M. Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex. J. Biol. Chem. 273 (1998) 11783-11790
63. Oyake T., Itoh K., Motohashi H., Hayashi N., Hoshino H., Nishizawa M., Yamamoto M., and Igarashi K. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16 (1996) 6083-6095
64. Sun J., Hoshino H., Takaku K., Nakajima O., Muto A., Suzuki H., Tashiro S., Takahashi S., Shibahara S., Alam J., Taketo M.M., Yamamoto M., and Igarashi K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 21 (2002) 5216-5224
65. Oyake T., Itoh K., Motohashi H., Hayashi N., Hoshino H., Nishizawa M., Yamamoto M., and Igarashi K. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 11 (1996) 6083-6095
66. Dhakshinamoorthy S., Jain A.K., Bloom D.A., and Jaiswal A.K. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J. Biol. Chem. 280 (2005) 16891-16900
67. Jain A.K., Bloom D.A., and Jaiswal A.K. Nuclear import and export signals in control of Nrf2. J. Biol. Chem. 280 (2005) 29158-29168
68. Kannoji A., Phukan S., Sudher Babu V., and Balaji V.N. GSK3beta: a master switch and a promising target. Expert Opin. Ther. Targets 11 (2008) 1443-1455
69. Jain A.K., and Jaiswal A.K. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J. Biol. Chem. 282 (2007) 16502-16510
70. Jain A.K., and Jaiswal A.K. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 281 (2006) 12132-12142
71. Giudice A., and Montella M. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. BioEssays 28 (2006) 169-181
72. Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003) 768-780
73. Lee J.-S., and Surh Y.-J. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224 (2005) 171-184
74. Kang K.W., Cho I.J., Lee C.H., and Kim S.G. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz. J. Natl. Cancer Inst. 95 (2003) 53-66
75. Kensler T.W., Qian G.S., Chen J.G., and Groopman D. Translational strategies for cancer prevention in liver. Nat. Rev. Cancer 3 (2003) 321-329
76. Pietsch E.C., Chan J.Y., Torti F.M., and Torti V. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J. Biol. Chem. 278 (2003) 2361-2369
77. Kwak M.K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., and Kensler T.W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival. J. Biol. Chem. 278 (2003) 8135-8145
78. Kwak M.K., Egner P.A., Dolan P.M., Ramos-Gomez M., Groopman J.D., Itoh K., Yamamoto M., and Kensler T.W. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 480/481 (2001) 305-315
79. Kwak M.K., Itoh K., Yamamoto M., and Kensler T.W. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the Nrf2 promoter. Mol. Cell. Biol. 22 (2002) 2883-2892
80. McMahon M., Itoh K., Yamamoto M., and Hayes J.D. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278 (2003) 21592-21600
81. Balogun E., Hoque M., Gong P., Killeen E., Green C.J., Foresti R., Alam J., and Motterlini R. Curcumin activates the haemoxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371 (2003) 887-895
82. Casalino E., Calzaretti G., Landriscina M., Sblano C., Fabiano A., and Landriscina C. The Nrf2 transcription factor contributes to the induction of alpha-class GST isoenzymes in liver of acute cadmium or manganese intoxicated rats: comparison with the toxic effect on NAD(P)H:quinone oxidoreductase. Toxicology 237 (2007) 24-34
83. Toyama T., Sumi D., Shinkai Y., Yasutake A., Taguchi K., Tong K.I., Yamamoto M., and Kumagai; Y. Cytoprotective role of Nrf2/Keap1 system in methylmercury toxicity. Biochem. Biophys. Res. Commun. 363 (2007) 645-650
84. Rajo A.I., Rada P., Egea J., Rosa A.O., Lopez M.G., and Cuadrado A. Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol. Cell. Neurosci. 39 (2008) 125-132
85. Johnson J.A., Johnson D.A., Kraft A.D., Calkins M.J., Jakel R.J., Vargas M.R., and Chen P.C. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 1147 (2008) 61-69
86. Chen P.C., Vargas M.R., Pank A.K., Smeyne R.J., Johnson D.A., Kan Y.W., and Johnson J.A. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. USA 106 (2009) 2933-2938
87. Reddy N.M., Kleeberger S.R., Kensler T.W., Yamamoto M., Hassoum P.M., and Reddy S.P. Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J. Immunol. 182 (2009) 7264-7271
88. Aoki Y., Sato H., Nishimura N., Takahashi S., Itoh K., and Yamamoto M. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173 (2001) 154-160
89. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., and Kensler T.W. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor deficient mice. Proc. Natl. Acad. Sci. USA 98 (2001) 3410-3415
90. Iida K., Itoh K., Kumagai Y., Oyasu R., Hattori K., Kawai K., Shimazui T., Akaza H., and Yamamoto M. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res. 64 (2004) 6424-6431
91. Sykiotis G.P., and Bohmann D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev. Cell 14 (2008) 76-85
92. Vollrath V., Wielandt A.M., Iruretagoyena M., and Chianale M. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem. J. 395 (2006) 599-609
93. Kim Y.J., Ahn J.Y., Liang P., Ip C., Zhang Y., and Park Y.M. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res. 67 (2007) 546-554
94. Okawa H., Motohashi H., Kobayashi A., Aburatani H., Kensler T.W., and Yamamoto M. Hepatocyte-specific deletion of the Keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 339 (2006) 79-88
95. Wang X.J., Sun Z., Villeneuve N.F., Zhang S., Zhao F., Li Y., Chen W., Yi X., Zheng Y.X., Wondrack G.T., Wong P.K., and Zhang D.D. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29 (2008) 1235-1243
96. Padmanabhan B., Tong K.I., Ohta T., Nakamura Y., Scharlock M., Ohtsuji M., Kang M.I., Kobayashi A., Yokoyama S., and Yamamoto M. Structural basis for defects of Keap1 activity provided by its point mutations in lung cancer. Mol. Cell 21 (2006) 689-734
97. Singh A., Misra V., Thimmulappa R.K., Lee H., Ames S., Hoque M.O., Herman J.G., Baylin S.B., Sidransky D., Gabrielson E., Brock M.V., and Biswal S. Dysfunctional Keap1-Nrf2 interaction in non-small-cell lung cancer. PLoS Med. 3 (2006) 1865-1876
98. Ohta T., Iijima K., Miyamoto M., Nakahara I., Tanaka H., Ohtsuji M., Suzuki T., Kobayashi A., Yokota J., Sakiyama T., Shibata T., Yamamoto M., and Hirohashi S. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68 (2008) 1303-1309
99. Nioi P., and Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 362 (2007) 816-821
100. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., and Hirohashi S. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135 (2008) 1358-1368
101. Shibata T., Ohta T., Tong K.I., Kokubu A., Odogawa R., Tsuta K., Asamura H., Yamamoto M., and Hirohashi S. Cancer related mutations in Nrf2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. USA 105 (2008) 13568-13573